β-CGRP, human, plays a significant role in various physiological processes, particularly in the regulation of blood flow and pain signaling. It is extensively studied for its potential therapeutic applications in migraine treatment, as it is involved in the dilation of blood vessels and the transmission of pain signals in the brain. By targeting β-CGRP, researchers aim to develop medications that can effectively reduce the frequency and severity of migraine attacks. Additionally, β-CGRP is being explored for its role in cardiovascular health, where it may help in managing conditions related to blood pressure and heart function. Its involvement in inflammatory responses also makes it a subject of interest for developing treatments for inflammatory diseases.